Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you live in Walsall and are weighing up Wegovy injections, the core question is straightforward: semaglutide (sold as Wegovy) is a once-weekly injection licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 or above alongside a weight-related condition. It is a prescription-only medicine, which means a qualified prescriber must assess your medical history before any treatment can be supplied. You can access it privately through a GPhC-registered online pharmacy without a GP referral or a waiting list, or through NHS specialist weight management services in the West Midlands, where demand currently outstrips capacity. Understanding how the medicine works, who it suits, and what responsible access looks like will help you make that call with confidence.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before anything else, eligibility shapes the decision. The Wegovy licence covers adults with a BMI of 30 or above, or a BMI between 27 and 29.9 where at least one weight-related condition is present — high blood pressure, type 2 diabetes, high cholesterol, obstructive sleep apnoea and cardiovascular disease are among those that count. Lower BMI thresholds apply for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, where UK guidance recognises that health risks occur at lower weights. BMI alone, though, is never the whole picture. A prescriber looks at your full medical history, any medicines you take, and conditions that would make semaglutide unsuitable — a personal or family history of medullary thyroid carcinoma, for example, is a contraindication. Wegovy is not licensed for use in pregnancy, during breastfeeding, or while actively trying to conceive, and it is not approved for people under 18.
The factual overview of what Wegovy injections are covers the licence in more detail if you want to read the clinical background before speaking to anyone. A BMI calculator on the NHS website can give you your number as a starting point, though it is genuinely just a starting point.
This is the fork in the road most people in Walsall reach. On the NHS, Wegovy is available through specialist weight management services under NICE guidance (TA875), which requires multidisciplinary support and caps treatment at two years. Referral routes go through your GP, but waiting lists in the West Midlands, as across England, are long. NICE's criteria specify a BMI of 35 or above alongside at least one weight-related comorbidity for NHS access at the standard threshold.
Private treatment is a different route. A GPhC-registered online pharmacy can carry out a consultation, have it reviewed by a prescriber the same day, and dispatch wegovy injections with next-working-day tracked delivery, no referral, no waiting list, subject to clinical suitability. If you are curious about what that process costs, the Wegovy cost page sets out the transparent pricing structure honestly, including what is and is not included. It is worth reading before assuming one route is out of reach.
One practical note on timing: if you are planning around a payday or a Monday order, knowing that weekday orders placed before 12pm can be dispatched the same day helps you plan ahead rather than wait until the following week.
Understanding the mechanics helps people stick with treatment. Semaglutide acts on GLP-1 receptors in the brain and gut, reducing appetite signals and slowing the rate at which food leaves the stomach. The result is that smaller portions satisfy more easily and the urge to eat between meals reduces. It is not a stimulant and it does not speed up metabolism directly, the weight loss comes from consuming less, supported by a changed hormonal environment.
The wegovy injection itself is subcutaneous (just under the skin) using a pre-filled pen. You rotate between sites (abdomen, thigh, upper arm) to avoid localised reactions. Pens are stored in the fridge at 2–8°C; the exact room-temperature window once removed is set out in the patient information leaflet, and your prescriber or the leaflet is the right source for that detail rather than a general article. Changing the needle before every injection is standard practice; our practical guide to how Wegovy injections work goes through the technique in more depth.
Side effects are mostly gastrointestinal, particularly in the early weeks: nausea, loose stools, constipation, reflux, and fatigue feature most commonly. They tend to be at their most noticeable after a dose step-up and ease for most people within a couple of weeks. The NHS semaglutide medicines page lists the full profile clearly and is worth bookmarking, and if you want to understand more about how semaglutide injections are used in weight management, that page covers the clinical detail alongside the side effect picture. Severe, persistent stomach pain that radiates towards the back is a symptom that warrants urgent medical attention, it can indicate pancreatitis, an infrequent but serious risk highlighted in an MHRA Drug Safety Update in January 2026.
Walsall has no shortage of adverts for weight-loss injections, some from sources that should give you pause. The legal position is unambiguous: Wegovy is a prescription-only medicine and cannot lawfully be supplied without a valid prescription following a proper clinical assessment. The MHRA has seized large quantities of counterfeit weight-loss pens sold through social media and informal channels, some containing substances other than what was claimed. Sellers offering these medicines without a prescription, at prices far below the legitimate market, or via Instagram direct messages are red flags. You can verify any online pharmacy on the GPhC register before sharing any personal or medical information with them.
At nume, our pharmacy holds GPhC premises registration 9012878 (verifiable directly on that register). Every consultation is read by a GPhC-registered Independent Prescriber, a real clinician, not automated triage software. Our about us page and clinical team profile are there if you want to know who is making those decisions. If you have questions before starting, the FAQs cover the most common ones, and our team is reachable through the contact page seven days a week.
When you are ready to find out whether you qualify, check your eligibility through a free consultation, there is no obligation and no charge for the assessment itself.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.